Jiangsu Yahong Pharmaceutical Technology Co., Ltd
Initial public offering and listing on the science and Innovation Board
Issuance announcement
Sponsor (lead underwriter): Citic Securities Company Limited(600030)
Scan QR code to view the full text of the announcement
Important tips
Jiangsu Yahong Pharmaceutical Technology Co., Ltd. (hereinafter referred to as “Yahong pharmaceutical”, “issuer” or “company”) in accordance with the implementation opinions on establishing a science and innovation board and pilot registration system in Shanghai Stock Exchange (CSRC announcement [2019] No. 2) issued by China Securities Regulatory Commission (hereinafter referred to as “CSRC” and “CSRC”) The measures for the administration of securities issuance and underwriting (CSRC order [No. 144]) (hereinafter referred to as the “measures”) and the measures for the administration of the registration of initial public offering of shares on the science and Innovation Board (for Trial Implementation) (CSRC order [No. 174]) are promulgated by Shanghai Stock Exchange (hereinafter referred to as the “Shanghai Stock Exchange”) Measures for the implementation of the issuance and underwriting of shares on the science and Innovation Board of Shanghai Stock Exchange (SZF [2021] No. 76) (hereinafter referred to as the “implementation measures”), guidelines for the application of the issuance and underwriting rules of the science and Innovation Board of Shanghai Stock Exchange No. 1 – initial public offering of shares (SZF [2021] No. 77) (hereinafter referred to as the “underwriting guidelines”) Detailed rules for the implementation of online issuance of initial public offerings in Shanghai market (SZF [2018] No. 40) (hereinafter referred to as “detailed rules for the implementation of online issuance”) and detailed rules for the implementation of offline issuance of initial public offerings in Shanghai market (SZF [2018] No. 41) (hereinafter referred to as “detailed rules for the implementation of offline issuance”), promulgated by China Securities Association Code for underwriting of initial public offerings under the registration system (zxsf [2021] No. 213), detailed rules for the administration of offline investors in initial public offerings (zxsf [2018] No. 142), rules for the administration of offline investors in initial public offerings under the registration system and guidelines for the classification, evaluation and management of offline investors in initial public offerings under the registration system (Zhong Zheng Xie Fa [2021] No. 212), as well as the relevant provisions of the Shanghai Stock Exchange on stock issuance and listing rules and the latest operating guidelines, IPO and listing on the science and innovation board.
For this offering, Citic Securities Company Limited(600030) (hereinafter referred to as ” Citic Securities Company Limited(600030) “, “sponsor (lead underwriter)” or “lead underwriter”) serves as the sponsor (lead underwriter).
This issuance adopts directional placement to strategic investors (hereinafter referred to as “strategic placement”), offline inquiry placement to qualified investors (hereinafter referred to as “offline issuance”), and online pricing issuance to social public investors holding the market value of non restricted A-Shares and non restricted depositary receipts in Shanghai market (hereinafter referred to as “online issuance”) ）Combined. Strategic placement, preliminary inquiry and online The offline issuance is organized and implemented by the sponsor (lead underwriter). The strategic placement of this issuance is carried out at the sponsor (lead underwriter). The preliminary inquiry and offline subscription are through the offline subscription electronic platform of IPO of Shanghai Stock Exchange (hereinafter referred to as “offline subscription platform”) ）The online issuance is conducted through the trading system of Shanghai Stock Exchange. Investors are requested to read this announcement carefully. For the details of preliminary inquiry and electronic offline issuance, please refer to the detailed rules for the implementation of offline issuance published on the website of Shanghai Stock Exchange (www.sse. Com.. CN).
Investors can visit the following website（ http://www.sse.com..cn./disclosure/listedinfo/listing/ 、 http://www.sse.com..cn./ipo/home/ ）Check the full text of the announcement.
Basic information of the issuer
The full name of the company is Jiangsu Yahong pharmaceutical technology securities, abbreviated as Yahong pharmaceutical
limited company
Securities code / offline subscription 688176 online subscription code 787176
code
Offline subscription referred to as Yahong pharmaceutical online subscription referred to as Yahong subscription
Basic information of this offering
Offline preliminary inquiry direct
The pricing method determines the issue price, and the number of offline issues (10000.11 million)
No more cumulative bids (shares)
inquiry
Total share capital after issuance (10000 shares of the issued amount)
19.30) proportion of total share capital after line 57000.00
（%）
High price rejection ratio (%) 1.01, whichever is lower (yuan / share) 22.3000
The issue price (yuan) / whether the issue price exceeds the issue price
Shares) 22.98, the lower of the four, the lower of the four, the range of excess
And the exceeding range (%) is 3.05%
Issue price earnings ratio (earnings per share)
According to the issued Market Research rate in 2020 (per share)
The non recurring expenses deducted from the audit shall be in accordance with 2020
The lower of profit and loss is not applicable to 76.14 times of annual audited R & D
Shareholders’ expenses attributable to the parent company divided by this offering
Net profit divided by total share capital after issuance)
Total share capital after the line (calculated)
Industry name and industry pharmaceutical manufacturing (C27) industry T-3 static 38.63 times
Industry code industry P / E ratio
Determined according to the issue price
Committed subscription strategy of 330.00 and committed subscription strategy of 3.00
Total sales (10000 shares) accounting for the proportion of total sales in this offering
Quantity ratio (%)
Strategic placement callback website 8580.00 strategic placement callback website 2090.00
Lower issue quantity (10000 shares) upper issue quantity (10000 shares)
Number of proposed offline subscriptions
Maximum amount (10000 shares) (application 4200) proposed offline subscription of 100
The purchase quantity shall be the lower limit of 100000 shares (10000 shares)
Integer multiple) number of proposed online subscriptions
Maximum amount (10000 shares) (application for 2.05 shares) placement brokerage commission of 0.50
The number of shares purchased shall be 500 shares at the whole rate (%)
Several times) according to the issuing price
Calculated estimated raised capital 252780.00 underwriting method balance underwriting
Total amount (10000 yuan)
Important date of this issuance
Offline Subscription Date and start and end 2021-12-27 (9:30) – online subscription date and start and end 2021-12-27 (9:30)-
Time (15:00) time (11:30, 13:00-15:00)
Offline payment date and deadline: 16:00 on December 29, 2021 online payment date and deadline: December 29, 2021
Time time
Remarks: 1 “The lower of the four numbers” refers to the lower of the median and weighted average of the remaining quotations of offline investors after excluding the highest quotation, as well as the median and weighted average of the remaining quotations of public products, social security funds and pensions.
The issuer and the recommendation institution (lead underwriter) solemnly remind investors to pay attention to investment risks and make rational investment, and carefully read this announcement and the information published in Shanghai Securities News, China Securities News, securities times and Securities Daily on December 24, 2021 (t-1) Special announcement on investment risk of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. in its initial public offering and listing on the science and Innovation Board (hereinafter referred to as “special announcement on investment risk”).
This announcement only briefly describes the issue of shares and does not constitute investment suggestions. Investors want to know the details of this offering, Please read carefully the letter of intent on initial public offering and listing on the science and Innovation Board of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the “letter of intent”) published on the website of Shanghai Stock Exchange (www.sse. Com.. CN) on December 17, 2021. The issuer and the sponsor (lead underwriter) hereby draw investors’ special attention to the contents of the letter of intent “Tips on major events” and “risk factors” chapters, fully understand the issuer’s risk factors, judge its operation status and investment value, and make investment decisions prudently. The issuer’s operating conditions may change due to the influence of politics, economy, industry and operation management level, and the possible investment risks shall be borne by the investors themselves.
The listing of the shares will be announced separately. 1、 Preliminary inquiry results and pricing
The application of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. for initial public offering of RMB common shares (A shares) and listing on the science and Innovation Board (hereinafter referred to as “this offering”) has been examined and approved by the stock listing committee of the science and Innovation Board of Shanghai Stock Exchange, and has been registered by CSRC Huitong Yi (zjxk [2021] No. 3797). The issuer’s shares are referred to as “Yahong pharmaceutical” , abbreviated as “Yahong medical technology”, with the stock code of “688176”, this code is also used for the preliminary inquiry and offline subscription of this issuance, and the online subscription code of this issuance is “787176”.
The issuance is carried out in a combination of strategic placement, offline issuance and online issuance.
(i) Preliminary inquiry
1. Overall declaration
The initial inquiry period of this offering is 9:30-15:00 on December 22 (T-3), 2021. As of 15:00 on December 22 (T-3), 2021, the sponsor (the lead underwriter) has received the preliminary inquiry and quotation information of 9663 placing objects managed by 374 offline investors through the offline subscription platform of Shanghai Stock Exchange, with the quotation range of 9.00 yuan / share – 125.20 yuan / share, and the total number of proposed subscriptions is 24038640 million shares. For the specific quotation of placing objects, please refer to the “attached table: preliminary inquiry and quotation of placing objects” of this announcement.
2. Investor verification
According to the conditions for offline investors participating in the preliminary inquiry published in the announcement on the issuance arrangement and preliminary inquiry of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. for initial public offering and listing on the science and Innovation Board (hereinafter referred to as the “announcement on issuance arrangement and preliminary inquiry”) published on December 17, 2021, the sponsor (lead underwriter) verified that 6 placing objects managed by 4 offline investors failed to provide audit materials or materials as required, but failed to pass the recommendation agency (lead underwriter) qualification review; 229 placing objects managed by 47 offline investors fall within the scope of prohibited placing; one placing object managed by one offline investor intends to apply for more than the asset scale or capital scale in the filing materials submitted; four placing objects managed by one offline investor fail to submit pricing basis and suggestions before the inquiry Negotiate price or price range. The quotations of 240 placing objects managed by the above 52 offline investors have been determined to be invalid and eliminated, and the total number of shares to be purchased is 3821.1 million. For details, see the parts marked as “invalid quotation 1”, “invalid quotation 2”, “invalid quotation 3” and “invalid quotation 4” in the attached table “preliminary inquiry and quotation of placing object”.
After excluding the above invalid quotations, the 9423 placing objects managed by the remaining 371 offline investors all meet the conditions of offline investors specified in the announcement on issuance arrangement and preliminary inquiry, with a quotation range of 9.00 yuan / share – 125.20 yuan / share, and the total number of shares to be purchased is 23656530 million.
（2） Excluding the highest quotation
1. Elimination
After the issuer and the recommendation institution (lead underwriter) rank the purchase price from high to low according to the inquiry results after excluding the above invalid quotation, and calculate the cumulative total amount of proposed purchase corresponding to each price, the issuer and the recommendation institution (lead underwriter) rank the same purchase price according to the proposed purchase quantity of the placing object from small to large, and the same proposed purchase quantity at the same purchase price according to the reporting time
